Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 11:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 2,550 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Prematurity
Interventions: Ultrasound; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 2 Years to 4 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Autism Spectrum Disorder, Physical Activity, Anxiety, Mobile Health
Interventions: Mobile Health for Physical Activity Behavior Change; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Autism
Interventions: cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells; Biological
Lead sponsor: The Foundation for Orthopaedics and Regenerative Medicine; Other
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Naples, Florida

Conditions: Anxiety Disorders, Separation Anxiety Disorder, Social Anxiety Disorder, Specific Phobia, Generalized Anxiety Disorder
Interventions: Therapist-Assisted by Telephone, Self-Help; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 8 Years to 13 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: San Diego, California

Conditions: ADHD
Interventions: Atomoxetine Hydrochloride; Drug
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 6 Years to 18 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Autism Spectrum Disorder
Interventions: Fluconazole; Drug
Lead sponsor: The Center for Autism and Related Disorders; Other
Eligibility: 3 Years to 10 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 3
States / cities: Tarzana, California • Melbourne, Florida • Austin, Texas

Conditions: Autism Spectrum Disorder
Interventions: Anatomical MRI Scan; Diagnostic Test
Lead sponsor: San Diego State University; Other
Eligibility: 40 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: San Diego, California

Conditions: Development; Delayed, Mental, Anxiety, Situational Anxiety, Fear of Other Medical Care, Behavior, Coping, Behavior Disorders, Psychological Disorder, Behavior Disorders in Children
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Language Development Disorders, Autism Spectrum Disorder
Interventions: Enhanced Milieu Teaching, no intervention comparison group; Behavioral · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 30 Months and older
Enrollment: 156 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Autism Spectrum Disorder
Interventions: Assessment, Monitoring & Intervention; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 5 Months to 12 Months
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Pervasive Development Disorders
Interventions: placebo, extended-release guanfacine; Other · Drug
Lead sponsor: Yale University; Other
Eligibility: 5 Years to 14 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 5
States / cities: Los Angeles, California • New Haven, Connecticut • Atlanta, Georgia + 2 more

Conditions: Autism Spectrum Disorder, Autism, Anxiety, Anxiety Disorders, Generalized Anxiety Disorder, Social Anxiety Disorder
Interventions: LUNA-Adolescent, Treatment as Usual; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 11 Years to 17 Years
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Autistic Disorder
Interventions: Pregnenolone; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Stanford, California

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Transcranial Direct Current Stimulation; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 66 Years
Enrollment: 83 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: ADHD
Interventions: CLONICEL (clonidine HCl sustained release), Placebo; Drug
Lead sponsor: Addrenex Pharmaceuticals, Inc.; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 23
States / cities: Little Rock, Arkansas • El Centro, California • Irvine, California + 18 more

Conditions: Intellectual Disability, Developmental Disability
Interventions: Written language intervention; Behavioral
Lead sponsor: Baylor University; Other
Eligibility: 18 Years to 26 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Waco, Texas

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Flutemetamol (18F) Injection; Drug
Lead sponsor: GE Healthcare; Industry
Eligibility: 60 Years and older
Enrollment: 365 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Communication Disabilities
Interventions: Healthcare team- + patient-directed intervention, Healthcare team-directed intervention; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years and older
Enrollment: 687 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 5
States / cities: Denver, Colorado • Lone Tree, Colorado • Chicago, Illinois + 2 more

Conditions: Conduct Disorder, Oppositional Defiant Disorder
Interventions: Reward-Emphasized Treatment, Standard Treatment; Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 7 Years to 12 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Autism Spectrum Disorder
Interventions: Caregiver-Mediated Intervention, Caregiver-Education Intervention; Behavioral
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Months to 36 Months
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Congenital Heart Disease in Children, Hypoxia, Neurodevelopmental Disorders, Complex Congenital Heart Disease
Interventions: Single Arm, Neonatal Neurobehavioral Scale; Procedure
Lead sponsor: University of Utah; Other
Eligibility: 0 Years to 52 Years · Female only
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 5
States / cities: San Francisco, California • Washington D.C., District of Columbia • Scarborough, Maine + 1 more

Conditions: Premature Birth
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 25 Weeks to 34 Weeks
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Autism Spectrum Disorder
Interventions: Magnetic Resonance Therapy (MRT)-Active, Magnetic Resonance Therapy (MRT)-Sham; Device
Lead sponsor: Wave Neuroscience; Industry
Eligibility: 4 Years to 12 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Newport Beach, California • Buford, Georgia

Conditions: Autism Spectrum Disorder
Interventions: Project Personality, Sharing Feelings Intervention; Behavioral
Lead sponsor: Stony Brook University; Other
Eligibility: 11 Years to 16 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Stony Brook, New York

Search by objective public record fields.

Ultrasound, Peds Body Composition, and Neurodevelopmental Outcomes

Gamified App on Increasing Physical Activity and Reducing Anxiety in Autism

Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Autism

Treatment Study for Rural Latino Youth With Anxiety

Atomoxetine PBPK-PD Clinical Study

Study of Fluconazole in Children With Autism Spectrum Disorder

Age-related Changes in Myeloarchitectonics Across Adulthood in Autism Spectrum Disorder

Adaptive Care in the Perioperative Setting

Parent-Level Predictors of Early Language Interaction Quality and Intervention Outcomes

Early Connections, Early Detection and Intervention in Infants at Risk for Autism

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety

A Study of Pregnenolone in the Treatment of Individuals With Autism

Neuromodulation of Executive Function in the ADHD Brain

CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD

Written Language Intervention for Adults With Intellectual and Developmental Disabilities

Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease

Improving Communication and Healthcare Outcomes for Patients With Communication Disabilities

Behavioral Treatment for Children With Conduct Problems and Callous-Unemotional Traits

Optimizing Social and Communication Outcomes for Toddlers With Autism

Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

US and Neurodevelopmental Outcomes in the Neonatal Intensive Care Unit (NICU)

A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism

Promoting Resilience in Teens With ASD